Investor React Positively To Thermo Fisher's Annual Guidance

Benzinga2021-09-17
  • Thermo Fisher Scientific Inc (NYSE:TMO) provided initial revenue and earnings guidance for 2022 while reiterating previously disclosed financial guidance for full-year 2021.
  • Related: Thermo Fisher's Q2 Earnings Beat Expectations; Raises FY21 Outlook.
  • The Company said it anticipates total revenues of $40.3 billion for next year, a 12% increase over its $35.9 billion in revenues expected for 2021. 
  • Adjusted earnings per share are expected to be $21.16. Wall Street analysts, on average, were projecting $34.3 billion in 2022 revenues and EPS of $19.68.
  • Price Action: TMO shares are up 8.06% at $605.61 during the market session on the last check Friday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment